Drug Interactions between MiraLAX and Movantik
This report displays the potential drug interactions for the following 2 drugs:
- MiraLAX (polyethylene glycol 3350)
- Movantik (naloxegol)
Interactions between your drugs
No interactions were found between MiraLAX and Movantik. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Miralax is in the drug class laxatives.
- Miralax is used to treat the following conditions:
- Movantik is in the drug class peripheral opioid receptor antagonists.
- Movantik is used to treat the following conditions:
Drug and food interactions
Applies to: Movantik (naloxegol)
Do not consume grapefruit or grapefruit juice during treatment with naloxegol. Grapefruit juice can significantly increase the blood levels of naloxegol. You may be more likely to experience side effects and withdrawal symptoms such as sweating, tearing, runny nose, chills, diarrhea, abdominal pain, anxiety, insomnia, irritability, restlessness, and yawning. Taking naloxegol with food can also increase its absorption into the blood stream. Therefore, you should take it on an empty stomach at least 1 hour before or 2 hours after a meal. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.